enischio.com
to help
make
it happen
website under construction
Independent consultant for pharmaceutical companies, startups and university spin-offs, with the mission of enhancing ideas and products in early phase of development.
Committed to
- Increase value
- Increase knowledge
- Decrease technical risk
- Optimize sustainability
Why ENISCHIO?
Greek ενισχύω
Pronunciation enischìo
English: strengthen, nourish, reinforce, enhance.
Italiano: rafforzare, invigorire, infondere in altri forza confidenza, valore.
ABOUT ME.
Aim of my consultant activity is to share technical knowledge and more then 30 years of experience in research and development of new solutions, throughout the phases of discovery, early and late development.
I have worked for many years in primary as well in secondary research in academia and in the industry in Italy and abroad. My original technical background is on molecular pharmacology and electrophysiology.
While I have focused my activities on the neurobiology field, I had the opportunity to work in several research areas and in the R&D of several therapeutic areas including wellbeing products, pain relief, disinfection.
During my manager experience in the pharmaceutical industry, I have worked in scouting and evaluating opportunities. As member of many Due Diligence teams from early to late-stage projects, I have evaluated several hundreds of new products, platforms, and research programs, spanning from small molecules, biologic and medical devices.
Experience in scientific networking, public-private partnership throughout the industry value chain.
Competencies on Project management, Team building and Research strategy, as well as Competitive intelligence experience to provides crucial technical insights and support business strategies. Significant part of my activities was dedicated to creation and management of Intellectual Properties to support product/project value proposition.
Passionate about life science transformation through technology.
My mantra is : “Focus, Enthusiasm, Accountability”.
Starting from the most relevant "what if" questions
WORKING NOTE
Early phase of any development process is characterized by Ambiguity - Uncertainty - Complexity.
Thus, the main effort of the collaboration is first focussed on define a clear value proposition.
Next the main task is to highlight the vision and the strategy to obtain adeguate resources for following validation phase.
Finally, support throughout the collaboration is provided to the ensure the best commercial exploitation of the project
Society for Neuroscience
Societa' Italiana di Farmacologia
“For there is always light,
if only we're brave enough to see it -
If only we are brave enough to be it”
Amanda Gorman